Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.180
0.00 (0.00%)
At close: Feb 13, 2026

HKG:2348 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,1391,158905.83811.68577.74730.99
Short-Term Investments
220.84242.3410788.844.330.02
Trading Asset Securities
261.35207.14160.87181.36208.18201.12
Cash & Short-Term Investments
1,6211,6081,1741,082830.22962.12
Cash Growth
-4.10%36.98%8.49%30.31%-13.71%-16.18%
Accounts Receivable
247.27267.89322402.85346.78330.75
Other Receivables
----20.8-
Receivables
247.27267.89322402.85367.58330.75
Inventory
254.1308.24211.11241.75203.48246.03
Prepaid Expenses
11.887.3813.414.9915.59.75
Other Current Assets
-11-2.5894.260.07
Total Current Assets
2,1352,2021,7201,7441,5111,549
Property, Plant & Equipment
1,1941,2281,2171,3011,143781.95
Long-Term Investments
20202025.3587.2598.67
Goodwill
241.16241.16241.16241.16241.16241.16
Other Intangible Assets
277.93164.77160.31109.4897.9936.18
Long-Term Deferred Tax Assets
4.465.4718.986.865.756.53
Long-Term Deferred Charges
-136.16128185.54189.03170.54
Other Long-Term Assets
10.1111.0810.37.5614.3620
Total Assets
3,8834,0093,6233,6733,3402,904
Accounts Payable
204.88221.56162.16224.07143.21157.61
Accrued Expenses
-99.34108.27171.28156.94125.79
Short-Term Debt
929.86120.066.4321.01-
Current Portion of Leases
0.161.160.361.530.980.92
Current Income Taxes Payable
4.152.645.238.6515.59.3
Current Unearned Revenue
-32.7317.929.6614.458.47
Other Current Liabilities
228.77167.35214.96490.43345.01177.81
Total Current Liabilities
446.96554.6668.94932.06697.1479.91
Long-Term Leases
-3.70.10.441.532.03
Long-Term Unearned Revenue
3.363.36-0.30.60.9
Long-Term Deferred Tax Liabilities
129.37120.9594.3889.9866.8761.72
Other Long-Term Liabilities
----175.6175.6
Total Liabilities
579.69682.61763.431,023941.7720.14
Common Stock
80.5880.5380.4680.3980.3781.07
Additional Paid-In Capital
107.09105.95104.41103.09102.7100.18
Retained Earnings
3,0973,1022,6492,4362,1741,940
Treasury Stock
------0.43
Comprehensive Income & Other
18.7435.521.2422.5123.249.26
Total Common Equity
3,3033,3242,8552,6422,3812,171
Minority Interest
-2.44.587.9117.1513.09
Shareholders' Equity
3,3033,3272,8592,6502,3982,184
Total Liabilities & Equity
3,8834,0093,6233,6733,3402,904
Total Debt
9.1634.72120.538.4123.522.95
Net Cash (Debt)
1,6121,5731,0531,073806.7959.17
Net Cash Growth
7.30%49.36%-1.89%33.06%-15.90%3.35%
Net Cash Per Share
1.071.040.700.710.530.62
Filing Date Shares Outstanding
1,5021,5021,5001,4991,4981,505
Total Common Shares Outstanding
1,5021,5021,5001,4991,4981,505
Working Capital
1,6881,6481,051811.94813.931,069
Book Value Per Share
2.202.211.901.761.591.44
Tangible Book Value
2,7842,9182,4532,2912,0421,893
Tangible Book Value Per Share
1.851.941.641.531.361.26
Buildings
-788.38584.74531.28243.42309.25
Machinery
-634.79485.74721.4624.16749.76
Construction In Progress
-85.57356.9495.14675.2204.8
Leasehold Improvements
-6.686.666.646.595.98
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.